Bydureon vs Rybelsus

Bydureon (exenatide by AstraZeneca) is a once-weekly injection for type 2 diabetes, while Rybelsus (semaglutide by Novo Nordisk) is a daily pill for the same condition. The main differences are how they’re taken—Bydureon is a shot under the skin, and Rybelsus is a tablet swallowed by mouth—and their active ingredients, exenatide versus semaglutide.

AI summary of the sources below.